{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:35:47Z","timestamp":1792067747506,"version":"4.4.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100023561","name":"Ministerio de Universidades","doi-asserted-by":"publisher","award":["FPU16\/03953"],"award-info":[{"award-number":["FPU16\/03953"]}],"id":[{"id":"10.13039\/501100023561","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["09-PIN1-752 00015.6\/2022"],"award-info":[{"award-number":["09-PIN1-752 00015.6\/2022"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["S2022\/BMD-7209-INTEGRAMUNE-CM"],"award-info":[{"award-number":["S2022\/BMD-7209-INTEGRAMUNE-CM"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["09-PIN1-752 00015.6\/2022"],"award-info":[{"award-number":["09-PIN1-752 00015.6\/2022"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["S2022\/BMD-7209-INTEGRAMUNE-CM"],"award-info":[{"award-number":["S2022\/BMD-7209-INTEGRAMUNE-CM"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["S2022\/BMD-7209-INTEGRAMUNE-CM"],"award-info":[{"award-number":["S2022\/BMD-7209-INTEGRAMUNE-CM"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["2022\u2010C23.I01. P03.S0020\u20100000031"],"award-info":[{"award-number":["2022\u2010C23.I01. P03.S0020\u20100000031"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["FJC2021-047282-I"],"award-info":[{"award-number":["FJC2021-047282-I"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["FPI-SAF2017-82886-R"],"award-info":[{"award-number":["FPI-SAF2017-82886-R"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-106371RB-I00"],"award-info":[{"award-number":["PID2019-106371RB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2023-149541OB-I00"],"award-info":[{"award-number":["PID2023-149541OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"MEC | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CIBER CARDIOVASCULAR"],"award-info":[{"award-number":["CIBER CARDIOVASCULAR"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"MEC | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CIBER CARDIOVASCULAR"],"award-info":[{"award-number":["CIBER CARDIOVASCULAR"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"MEC | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP21\/00135"],"award-info":[{"award-number":["CP21\/00135"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"MEC | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/01842"],"award-info":[{"award-number":["PI22\/01842"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["PRYCO223002PEIN"],"award-info":[{"award-number":["PRYCO223002PEIN"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"'la Caixa' Foundation","doi-asserted-by":"publisher","award":["LCF\/PR\/HR23\/52430018"],"award-info":[{"award-number":["LCF\/PR\/HR23\/52430018"]}],"id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2025,7,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The L-Leu amino acid transporter SLC7A5 has become an important target in inflammation and cancer. However, its role in acute graft-versus-host disease (aGVHD) and graft versus tumor (GVT) remains unexplored. We demonstrate that SLC7A5 deletion affected T cell activation, expansion and survival, and reduced IFN\u03b3 and granzyme B expression, thus controlling aGVHD, but without effect on tumor growth. On the other hand, dietary restriction of L-Leu reduced aGVHD by controlling T cell expansion, inducing apoptosis, and affecting granzyme B secretion. However, CD8 T cells did not fail to activate and express IFN\u03b3 in the absence of L-Leu, and showed an increased proportion of central memory T cells, which contributed to the GVT response. Deletion of SLC7A5 in T cells compromises mTORC1, glycolysis and mitochondrial oxidation. On the contrary, L-Leu removal reduced mTORC1 and completely blocked glycolysis but preserved mitochondrial function, favoring the generation of central memory responses and expression of stemness marker TCF1. In addition, our metabolomics data underscores the L-Leu-derived metabolite \u03b2-hydroxybutyrate as an important marker for SLC7A5-dependent allogenic T cell expansion in aGVHD.<\/jats:p>","DOI":"10.1038\/s44321-025-00250-2","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T05:22:26Z","timestamp":1747804946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Restricting SLC7A5-mediated Leucine uptake in T cells prevents acute GVHD and maintains GVT response"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6968-1444","authenticated-orcid":false,"given":"Nieves","family":"Fern\u00e1ndez-Gallego","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0875-0734","authenticated-orcid":false,"given":"Blanca","family":"Anega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1674-228X","authenticated-orcid":false,"given":"Susana","family":"Luengo-Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maider","family":"Bizkarguenaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3541-9085","authenticated-orcid":false,"given":"Rub\u00e9n","family":"Gil-Redondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9878-3290","authenticated-orcid":false,"given":"Nieves","family":"Embade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Navarrete-Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ram\u00edrez-Huesca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6937-8801","authenticated-orcid":false,"given":"Emigdio","family":"\u00c1lvarez-Corrales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4548-4435","authenticated-orcid":false,"given":"Sara G","family":"Dosil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9877-2126","authenticated-orcid":false,"given":"Raquel","family":"Castillo-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0177-5644","authenticated-orcid":false,"given":"Amelia","family":"Rojas-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Espeleta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mart\u00ednez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3732-5816","authenticated-orcid":false,"given":"Arantzazu","family":"Alfranca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3785-5868","authenticated-orcid":false,"given":"Virginia","family":"G de Yebenes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0439-8979","authenticated-orcid":false,"given":"Noa Beatriz","family":"Mart\u00edn-C\u00f3freces","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0193-4679","authenticated-orcid":false,"given":"Juli\u00e1n","family":"Aragon\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2392-1764","authenticated-orcid":false,"given":"Pilar","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8748-4105","authenticated-orcid":false,"given":"Oscar","family":"Millet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5303-0762","authenticated-orcid":false,"given":"Francisco","family":"S\u00e1nchez-Madrid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4908-2639","authenticated-orcid":false,"given":"Danay","family":"Cibrian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"250_CR1","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1182\/blood-2016-08-731166","volume":"129","author":"N Bartolome-Izquierdo","year":"2017","unstructured":"Bartolome-Izquierdo N, de Yebenes VG, Alvarez-Prado AF, Mur SM, Lopez Del Olmo JA, Roa S, Vazquez J, Ramiro AR (2017) miR-28 regulates the germinal center reaction and blocks tumor growth in preclinical models of non-Hodgkin lymphoma. Blood 129:2408\u20132419","journal-title":"Blood"},{"key":"250_CR2","first-page":"1341","volume":"190","author":"G Bian","year":"2013","unstructured":"Bian G, Ding X, Leigh ND, Tang Y, Capitano ML, Qiu J, McCarthy PL, Liu H, Cao X (2013) Granzyme B-mediated damage of CD8+ T cells impairs graft-versus-tumor effect. J Immunol 190:1341\u20131350","journal-title":"J Immunol"},{"key":"250_CR3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2016.05.035","volume":"166","author":"MD Buck","year":"2016","unstructured":"Buck MD, O\u2019Sullivan D, Klein Geltink RI, Curtis JD, Chang CH, Sanin DE, Qiu J, Kretz O, Braas D, van der Windt GJ et al (2016) Mitochondrial dynamics controls T cell fate through metabolic programming. Cell 166:63\u201376","journal-title":"Cell"},{"key":"250_CR4","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.bbmt.2015.03.024","volume":"21","author":"PA Carpenter","year":"2015","unstructured":"Carpenter PA, Kitko CL, Elad S, Flowers ME, Gea-Banacloche JC, Halter JP, Hoodin F, Johnston L, Lawitschka A, McDonald GB et al (2015) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. The 2014 ancillary therapy and supportive care working group report. Biol Blood Marrow Transpl 21:1167\u20131187","journal-title":"Biol Blood Marrow Transpl"},{"key":"250_CR5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41577-019-0203-y","volume":"20","author":"NM Chapman","year":"2020","unstructured":"Chapman NM, Boothby MR, Chi H (2020) Metabolic coordination of T cell quiescence and activation. Nat Rev Immunol 20:55\u201370","journal-title":"Nat Rev Immunol"},{"key":"250_CR6","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood-2009-01-197178","volume":"114","author":"X Chen","year":"2009","unstructured":"Chen X, Das R, Komorowski R, Beres A, Hessner MJ, Mihara M, Drobyski WR (2009) Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease. Blood 114:891\u2013900","journal-title":"Blood"},{"key":"250_CR7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.4196\/kjpp.2017.21.6.599","volume":"21","author":"DW Choi","year":"2017","unstructured":"Choi DW, Kim DK, Kanai Y, Wempe MF, Endou H, Kim JK (2017) JPH203, a selective L-type amino acid transporter 1 inhibitor, induces mitochondria-dependent apoptosis in Saos2 human osteosarcoma cells. Korean J Physiol Pharm 21:599\u2013607","journal-title":"Korean J Physiol Pharm"},{"key":"250_CR8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jaci.2019.09.025","volume":"145","author":"D Cibrian","year":"2020","unstructured":"Cibrian D, Castillo-Gonzalez R, Fernandez-Gallego N, de la Fuente H, Jorge I, Saiz ML, Punzon C, Ramirez-Huesca M, Vicente-Manzanares M, Fresno M et al (2020) Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation. J Allergy Clin Immunol 145:199\u2013214.e111","journal-title":"J Allergy Clin Immunol"},{"key":"250_CR9","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ni.3504","volume":"17","author":"D Cibrian","year":"2016","unstructured":"Cibrian D, Saiz ML, de la Fuente H, Sanchez-Diaz R, Moreno-Gonzalo O, Jorge I, Ferrarini A, Vazquez J, Punzon C, Fresno M et al (2016) CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis. Nat Immunol 17:985\u2013996","journal-title":"Nat Immunol"},{"key":"250_CR10","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1158\/0008-5472.CAN-15-3376","volume":"76","author":"Y Cormerais","year":"2016","unstructured":"Cormerais Y, Giuliano S, LeFloch R, Front B, Durivault J, Tambutte E, Massard PA, de la Ballina LR, Endou H, Wempe MF et al (2016) Genetic disruption of the multifunctional CD98\/LAT1 complex demonstrates the key role of essential amino acid transport in the control of mTORC1 and tumor growth. Cancer Res 76:4481\u20134492","journal-title":"Cancer Res"},{"key":"250_CR11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/bmt.2009.41","volume":"44","author":"M Crowther","year":"2009","unstructured":"Crowther M, Avenell A, Culligan DJ (2009) Systematic review and meta-analyses of studies of glutamine supplementation in haematopoietic stem cell transplantation. Bone Marrow Transpl 44:413\u2013425","journal-title":"Bone Marrow Transpl"},{"key":"250_CR12","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1182\/bloodadvances.2021004941","volume":"5","author":"Z DeFilipp","year":"2021","unstructured":"DeFilipp Z, Alousi AM, Pidala JA, Carpenter PA, Onstad LE, Arai S, Arora M, Cutler CS, Flowers MED, Kitko CL et al (2021) Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium. Blood Adv 5:4278\u20134284","journal-title":"Blood Adv"},{"key":"250_CR13","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/s41423-020-0365-3","volume":"18","author":"N Dumauthioz","year":"2021","unstructured":"Dumauthioz N, Tschumi B, Wenes M, Marti B, Wang H, Franco F, Li W, Lopez-Mejia IC, Fajas L, Ho PC et al (2021) Enforced PGC-1alpha expression promotes CD8 T cell fitness, memory formation and antitumor immunity. Cell Mol Immunol 18:1761\u20131771","journal-title":"Cell Mol Immunol"},{"key":"250_CR14","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.molcel.2012.09.017","volume":"48","author":"A Elorza","year":"2012","unstructured":"Elorza A, Soro-Arnaiz I, Melendez-Rodriguez F, Rodriguez-Vaello V, Marsboom G, de Carcer G, Acosta-Iborra B, Albacete-Albacete L, Ordonez A, Serrano-Oviedo L et al (2012) HIF2alpha acts as an mTORC1 activator through the amino acid carrier SLC7A5. Mol Cell 48:681\u2013691","journal-title":"Mol Cell"},{"key":"250_CR15","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","volume":"373","author":"JL Ferrara","year":"2009","unstructured":"Ferrara JL, Levine JE, Reddy P, Holler E (2009) Graft-versus-host disease. Lancet 373:1550\u20131561","journal-title":"Lancet"},{"key":"250_CR16","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1084\/jem.20112607","volume":"209","author":"DK Finlay","year":"2012","unstructured":"Finlay DK, Rosenzweig E, Sinclair LV, Feijoo-Carnero C, Hukelmann JL, Rolf J, Panteleyev AA, Okkenhaug K, Cantrell DA (2012) PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells. J Exp Med 209:2441\u20132453","journal-title":"J Exp Med"},{"key":"250_CR17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.mam.2012.10.007","volume":"34","author":"D Fotiadis","year":"2013","unstructured":"Fotiadis D, Kanai Y, Palacin M (2013) The SLC3 and SLC7 families of amino acid transporters. Mol Asp Med 34:139\u2013158","journal-title":"Mol Asp Med"},{"key":"250_CR18","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3390\/metabo12121206","volume":"12","author":"R Gil-Redondo","year":"2022","unstructured":"Gil-Redondo R, Conde R, Bizkarguenaga M, Bruzzone C, Lain A, Gonzalez-Valle B, Iriberri M, Ramos-Acosta C, Anguita E, Arriaga Lariz JI et al (2022) An NMR-based model to investigate the metabolic phenoreversion of COVID-19 patients throughout a longitudinal study. Metabolites 12:1206","journal-title":"Metabolites"},{"key":"250_CR19","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1182\/blood.V87.4.1232.bloodjournal8741232","volume":"87","author":"TA Graubert","year":"1996","unstructured":"Graubert TA, Russell JH, Ley TJ (1996) The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection. Blood 87:1232\u20131237","journal-title":"Blood"},{"key":"250_CR20","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.cell.2012.02.044","volume":"149","author":"JM Han","year":"2012","unstructured":"Han JM, Jeong SJ, Park MC, Kim G, Kwon NH, Kim HK, Ha SH, Ryu SH, Kim S (2012) Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. Cell 149:410\u2013424","journal-title":"Cell"},{"key":"250_CR21","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.4049\/jimmunol.1300923","volume":"191","author":"K Hayashi","year":"2013","unstructured":"Hayashi K, Jutabha P, Endou H, Sagara H, Anzai N (2013) LAT1 is a critical transporter of essential amino acids for immune reactions in activated human T cells. J Immunol 191:4080\u20134085","journal-title":"J Immunol"},{"key":"250_CR22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/all.14019","volume":"75","author":"K Hayashi","year":"2020","unstructured":"Hayashi K, Kaminuma O, Nishimura T, Saeki M, Matsuoka K, Hiroi T, Jutabha P, Iwata Y, Sugiura K, Owada T et al (2020) LAT1-specific inhibitor is effective against T cell-mediated allergic skin inflammation. Allergy 75:463\u2013467","journal-title":"Allergy"},{"key":"250_CR23","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/jclinpath-2020-206457","volume":"74","author":"M Ichinoe","year":"2021","unstructured":"Ichinoe M, Mikami T, Yanagisawa N, Yoshida T, Hana K, Endou H, Okayasu I, Sengoku N, Ogata H, Saegusa M et al (2021) Prognostic values of L-type amino acid transporter 1 and CD98hc expression in breast cancer. J Clin Pathol 74:589\u2013595","journal-title":"J Clin Pathol"},{"key":"250_CR24","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.celrep.2017.10.082","volume":"21","author":"K Ikeda","year":"2017","unstructured":"Ikeda K, Kinoshita M, Kayama H, Nagamori S, Kongpracha P, Umemoto E, Okumura R, Kurakawa T, Murakami M, Mikami N et al (2017) Slc3a2 mediates branched-chain amino-acid-dependent maintenance of regulatory T cells. Cell Rep. 21:1824\u20131838","journal-title":"Cell Rep."},{"key":"250_CR25","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1084\/jem.20130084","volume":"210","author":"D Jankovic","year":"2013","unstructured":"Jankovic D, Ganesan J, Bscheider M, Stickel N, Weber FC, Guarda G, Follo M, Pfeifer D, Tardivel A, Ludigs K et al (2013) The Nlrp3 inflammasome regulates acute graft-versus-host disease. J Exp Med 210:1899\u20131910","journal-title":"J Exp Med"},{"key":"250_CR26","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41385-022-00527-6","volume":"15","author":"SA Jansen","year":"2022","unstructured":"Jansen SA, Nieuwenhuis EES, Hanash AM, Lindemans CA (2022) Challenges and opportunities targeting mechanisms of epithelial injury and recovery in acute intestinal graft-versus-host disease. Mucosal Immunol 15:605\u2013619","journal-title":"Mucosal Immunol"},{"key":"250_CR27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00811-8","volume":"11","author":"N Jigjidkhorloo","year":"2021","unstructured":"Jigjidkhorloo N, Kanekura K, Matsubayashi J, Akahane D, Fujita K, Oikawa K, Kurata A, Takanashi M, Endou H, Nagao T et al (2021) Expression of L-type amino acid transporter 1 is a poor prognostic factor for Non-Hodgkin\u2019s lymphoma. Sci Rep. 11:21638","journal-title":"Sci Rep."},{"key":"250_CR28","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/s12276-024-01286-z","volume":"56","author":"YJ Kang","year":"2024","unstructured":"Kang YJ, Song W, Lee SJ, Choi SA, Chae S, Yoon BR, Kim HY, Lee JH, Kim C, Cho JY et al (2024) Inhibition of BCAT1-mediated cytosolic leucine metabolism regulates Th17 responses via the mTORC1-HIF1alpha pathway. Exp Mol Med 56:1776\u20131790","journal-title":"Exp Mol Med"},{"key":"250_CR29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41586-018-0806-7","volume":"565","author":"PWF Karmaus","year":"2019","unstructured":"Karmaus PWF, Chen X, Lim SA, Herrada AA, Nguyen TM, Xu B, Dhungana Y, Rankin S, Chen W, Rosencrance C et al (2019) Metabolic heterogeneity underlies reciprocal fates of T(H)17 cell stemness and plasticity. Nature 565:101\u2013105","journal-title":"Nature"},{"key":"250_CR30","doi-asserted-by":"crossref","first-page":"9571","DOI":"10.1073\/pnas.0503726102","volume":"102","author":"CA Klebanoff","year":"2005","unstructured":"Klebanoff CA, Gattinoni L, Torabi-Parizi P, Kerstann K, Cardones AR, Finkelstein SE, Palmer DC, Antony PA, Hwang ST, Rosenberg SA et al (2005) Central memory self\/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci USA 102:9571\u20139576","journal-title":"Proc Natl Acad Sci USA"},{"key":"250_CR31","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.4049\/jimmunol.176.7.3966","volume":"176","author":"M Laforge","year":"2006","unstructured":"Laforge M, Bidere N, Carmona S, Devocelle A, Charpentier B, Senik A (2006) Apoptotic death concurrent with CD3 stimulation in primary human CD8+ T lymphocytes: a role for endogenous granzyme B. J Immunol 176:3966\u20133977","journal-title":"J Immunol"},{"key":"250_CR32","doi-asserted-by":"crossref","first-page":"1192084","DOI":"10.3389\/fimmu.2023.1192084","volume":"14","author":"R Limpert","year":"2023","unstructured":"Limpert R, Pan P, Wang L-S, Chen X (2023) From support to therapy: rethinking the role of nutrition in acute graft-versus-host disease. Front Immunol 14:1192084","journal-title":"Front Immunol"},{"key":"250_CR33","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.bbmt.2009.07.015","volume":"15","author":"Y Lu","year":"2009","unstructured":"Lu Y, Waller EK (2009) Dichotomous role of interferon-gamma in allogeneic bone marrow transplant. Biol Blood Marrow Transpl 15:1347\u20131353","journal-title":"Biol Blood Marrow Transpl"},{"key":"250_CR34","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.immuni.2023.07.002","volume":"56","author":"KM Luda","year":"2023","unstructured":"Luda KM, Longo J, Kitchen-Goosen SM, Duimstra LR, Ma EH, Watson MJ, Oswald BM, Fu Z, Madaj Z, Kupai A et al (2023) Ketolysis drives CD8(+) T cell effector function through effects on histone acetylation. Immunity 56:2021\u20132035.e2028","journal-title":"Immunity"},{"key":"250_CR35","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.bbmt.2012.04.005","volume":"18","author":"PJ Martin","year":"2012","unstructured":"Martin PJ, Rizzo JD, Wingard JR, Ballen K, Curtin PT, Cutler C, Litzow MR, Nieto Y, Savani BN, Schriber JR et al (2012) First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transpl 18:1150\u20131163","journal-title":"Biol Blood Marrow Transpl"},{"key":"250_CR36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ni.3400","volume":"17","author":"ND Mathewson","year":"2016","unstructured":"Mathewson ND, Jenq R, Mathew AV, Koenigsknecht M, Hanash A, Toubai T, Oravecz-Wilson K, Wu SR, Sun Y, Rossi C et al (2016) Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol 17:505\u2013513","journal-title":"Nat Immunol"},{"key":"250_CR37","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.trecan.2023.06.003","volume":"9","author":"CL McIntyre","year":"2023","unstructured":"McIntyre CL, Temesgen A, Lynch L (2023) Diet, nutrient supply, and tumor immune responses. Trends Cancer 9:752\u2013763","journal-title":"Trends Cancer"},{"key":"250_CR38","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8250","volume":"6","author":"R Milkereit","year":"2015","unstructured":"Milkereit R, Persaud A, Vanoaica L, Guetg A, Verrey F, Rotin D (2015) LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation. Nat Commun 6:7250","journal-title":"Nat Commun"},{"key":"250_CR39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.757836","volume":"12","author":"FA Mohamed","year":"2021","unstructured":"Mohamed FA, Thangavelu G, Rhee SY, Sage PT, O\u2019Connor RS, Rathmell JC, Blazar BR (2021) Recent metabolic advances for preventing and treating acute and chronic graft versus host disease. Front Immunol 12:757836","journal-title":"Front Immunol"},{"key":"250_CR40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.biocel.2015.08.004","volume":"67","author":"L Napolitano","year":"2015","unstructured":"Napolitano L, Scalise M, Galluccio M, Pochini L, Albanese LM, Indiveri C (2015) LAT1 is the transport competent unit of the LAT1\/CD98 heterodimeric amino acid transporter. Int J Biochem Cell Biol 67:25\u201333","journal-title":"Int J Biochem Cell Biol"},{"key":"250_CR41","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","volume":"136","author":"P Nicklin","year":"2009","unstructured":"Nicklin P, Bergman P, Zhang B, Triantafellow E, Wang H, Nyfeler B, Yang H, Hild M, Kung C, Wilson C et al (2009) Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 136:521\u2013534","journal-title":"Cell"},{"key":"250_CR42","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1021\/acs.analchem.1c04576","volume":"94","author":"P Nitschke","year":"2022","unstructured":"Nitschke P, Lodge S, Kimhofer T, Masuda R, Bong SH, Hall D, Schafer H, Spraul M, Pompe N, Diercks T et al (2022) J-Edited DIffusional proton nuclear magnetic resonance spectroscopic measurement of glycoprotein and supramolecular phospholipid biomarkers of inflammation in human serum. Anal Chem 94:1333\u20131341","journal-title":"Anal Chem"},{"key":"250_CR43","doi-asserted-by":"crossref","first-page":"G646","DOI":"10.1152\/ajpgi.00246.2012","volume":"304","author":"R Noth","year":"2013","unstructured":"Noth R, Hasler R, Stuber E, Ellrichmann M, Schafer H, Geismann C, Hampe J, Bewig B, Wedel T, Bottner M et al (2013) Oral glutamine supplementation improves intestinal permeability dysfunction in a murine acute graft-vs.-host disease model. Am J Physiol Gastrointest Liver Physiol 304:G646\u2013G654","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"250_CR44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1349-7006.2009.01386.x","volume":"101","author":"K Oda","year":"2010","unstructured":"Oda K, Hosoda N, Endo H, Saito K, Tsujihara K, Yamamura M, Sakata T, Anzai N, Wempe MF, Kanai Y et al (2010) L-type amino acid transporter 1 inhibitors inhibit tumor cell growth. Cancer Sci 101:173\u2013179","journal-title":"Cancer Sci"},{"key":"250_CR45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103031","volume":"138","author":"J Ogbechi","year":"2023","unstructured":"Ogbechi J, Wright HL, Balint S, Topping LM, Kristina Z, Huang YS, Pantazi E, Swart M, Windell D, Marin E et al (2023) LAT1 enables T cell activation under inflammatory conditions. J Autoimmun 138:103031","journal-title":"J Autoimmun"},{"key":"250_CR46","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LA O\u2019Neill","year":"2016","unstructured":"O\u2019Neill LA, Kishton RJ, Rathmell J (2016) A guide to immunometabolism for immunologists. Nat Rev Immunol 16:553\u2013565","journal-title":"Nat Rev Immunol"},{"key":"250_CR47","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108817","volume":"109","author":"T Owada","year":"2022","unstructured":"Owada T, Kurasawa K, Endou H, Fujita T, Anzai N, Hayashi K (2022) LAT1-specific inhibitor ameliorates severe autoimmune arthritis in SKG mouse. Int Immunopharmacol 109:108817","journal-title":"Int Immunopharmacol"},{"key":"250_CR48","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41409-023-01943-3","volume":"58","author":"JR Passweg","year":"2023","unstructured":"Passweg JR, Baldomero H, Ciceri F, Corbacioglu S, de la Camara R, Dolstra H, Glass B, Greco R, McLornan DP, Neven B et al (2023) Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey. Bone Marrow Transpl 58:647\u2013658","journal-title":"Bone Marrow Transpl"},{"key":"250_CR49","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112828","volume":"42","author":"LR Pelgrom","year":"2023","unstructured":"Pelgrom LR, Davis GM, O\u2019Shaughnessy S, Wezenberg EJM, Van Kasteren SI, Finlay DK, Sinclair LV (2023) QUAS-R: an SLC1A5-mediated glutamine uptake assay with single-cell resolution reveals metabolic heterogeneity with immune populations. Cell Rep 42:112828","journal-title":"Cell Rep"},{"key":"250_CR50","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1016\/j.bbmt.2020.08.004","volume":"26","author":"AZ Pereira","year":"2020","unstructured":"Pereira AZ, Goncalves SEA, Rodrigues M, Hamerschlak N, Flowers ME (2020) Challenging and practical aspects of nutrition in chronic graft-versus-host disease. Biol Blood Marrow Transpl 26:e265\u2013e270","journal-title":"Biol Blood Marrow Transpl"},{"key":"250_CR51","doi-asserted-by":"crossref","first-page":"e89547","DOI":"10.1371\/journal.pone.0089547","volume":"9","author":"N Poncet","year":"2014","unstructured":"Poncet N, Mitchell FE, Ibrahim AF, McGuire VA, English G, Arthur JS, Shi YB, Taylor PM (2014) The catalytic subunit of the system L1 amino acid transporter (slc7a5) facilitates nutrient signalling in mouse skeletal muscle. PLoS ONE 9:e89547","journal-title":"PLoS ONE"},{"key":"250_CR52","doi-asserted-by":"crossref","DOI":"10.1007\/s11306-015-0880-x","volume":"12","author":"H Reikvam","year":"2016","unstructured":"Reikvam H, Hatfield K, Bruserud O (2016) The pretransplant systemic metabolic profile reflects a risk of acute graft versus host disease after allogeneic stem cell transplantation. Metabolomics 12:12","journal-title":"Metabolomics"},{"key":"250_CR53","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/leu.2014.338","volume":"29","author":"C Rosilio","year":"2015","unstructured":"Rosilio C, Nebout M, Imbert V, Griessinger E, Neffati Z, Benadiba J, Hagenbeek T, Spits H, Reverso J, Ambrosetti D et al (2015) L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma\/T-cell acute lymphoblastic leukemia. Leukemia 29:1253\u20131266","journal-title":"Leukemia"},{"key":"250_CR54","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1182\/bloodadvances.2020003080","volume":"5","author":"M Roussel","year":"2021","unstructured":"Roussel M, Le KS, Granier C, Llamas Gutierrez F, Foucher E, Le Gallou S, Pangault C, Xerri L, Launay V, Lamy T et al (2021) Functional characterization of PD1+TIM3+ tumor-infiltrating T cells in DLBCL and effects of PD1 or TIM3 blockade. Blood Adv 5:1816\u20131829","journal-title":"Blood Adv"},{"key":"250_CR55","doi-asserted-by":"crossref","first-page":"7797","DOI":"10.1073\/pnas.0800928105","volume":"105","author":"S Sauer","year":"2008","unstructured":"Sauer S, Bruno L, Hertweck A, Finlay D, Leleu M, Spivakov M, Knight ZA, Cobb BS, Cantrell D, O\u2019Connor E et al (2008) T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci USA 105:7797\u20137802","journal-title":"Proc Natl Acad Sci USA"},{"key":"250_CR56","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ccr.2011.03.012","volume":"19","author":"JH Sheen","year":"2011","unstructured":"Sheen JH, Zoncu R, Kim D, Sabatini DM (2011) Defective regulation of autophagy upon leucine deprivation reveals a targetable liability of human melanoma cells in vitro and in vivo. Cancer Cell 19:613\u2013628","journal-title":"Cancer Cell"},{"key":"250_CR57","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.immuni.2019.10.001","volume":"51","author":"H Shi","year":"2019","unstructured":"Shi H, Chapman NM, Wen J, Guy C, Long L, Dhungana Y, Rankin S, Pelletier S, Vogel P, Wang H et al (2019) Amino acids license kinase mTORC1 activity and Treg cell function via small G proteins Rag and Rheb. Immunity 51:1012\u20131027.e1017","journal-title":"Immunity"},{"key":"250_CR58","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.20110278","volume":"208","author":"LZ Shi","year":"2011","unstructured":"Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR, Chi H (2011) HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med 208:1367\u20131376","journal-title":"J Exp Med"},{"key":"250_CR59","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","volume":"50","author":"I Siddiqui","year":"2019","unstructured":"Siddiqui I, Schaeuble K, Chennupati V, Fuertes Marraco SA, Calderon-Copete S, Pais Ferreira D, Carmona SJ, Scarpellino L, Gfeller D, Pradervand S et al (2019) Intratumoral Tcf1(+)PD-1(+)CD8(+) T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy. Immunity 50:195\u2013211.e110","journal-title":"Immunity"},{"key":"250_CR60","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ni.2556","volume":"14","author":"LV Sinclair","year":"2013","unstructured":"Sinclair LV, Rolf J, Emslie E, Shi YB, Taylor PM, Cantrell DA (2013) Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat Immunol 14:500\u2013508","journal-title":"Nat Immunol"},{"key":"250_CR61","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cmet.2016.10.018","volume":"24","author":"PJ Siska","year":"2016","unstructured":"Siska PJ, Rathmell JC (2016) Metabolic signaling drives IFN-gamma. Cell Metab 24:651\u2013652","journal-title":"Cell Metab"},{"key":"250_CR62","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1182\/blood.2021013244","volume":"139","author":"D Subburaj","year":"2022","unstructured":"Subburaj D, Ng B, Kariminia A, Abdossamadi S, Lauener M, Nemecek ER, Rozmus J, Kharbanda S, Kitko CL, Lewis VA et al (2022) Metabolomic identification of alpha-ketoglutaric acid elevation in pediatric chronic graft-versus-host disease. Blood 139:287\u2013299","journal-title":"Blood"},{"key":"250_CR63","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1182\/blood-2004-10-3869","volume":"105","author":"PA Taylor","year":"2005","unstructured":"Taylor PA, Panoskaltsis-Mortari A, Freeman GJ, Sharpe AH, Noelle RJ, Rudensky AY, Mak TW, Serody JS, Blazar BR (2005) Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM). Blood 105:3372\u20133380","journal-title":"Blood"},{"key":"250_CR64","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.aab2674","volume":"351","author":"RL Wolfson","year":"2016","unstructured":"Wolfson RL, Chantranupong L, Saxton RA, Shen K, Scaria SM, Cantor JR, Sabatini DM (2016) Sestrin2 is a leucine sensor for the mTORC1 pathway. Science 351:43\u201348","journal-title":"Science"},{"key":"250_CR65","volume":"14","author":"H Wu","year":"2023","unstructured":"Wu H, Zhao X, Hochrein SM, Eckstein M, Gubert GF, Knopper K, Mansilla AM, Oner A, Doucet-Ladeveze R, Schmitz W et al (2023) Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1alpha-mediated glycolytic reprogramming. Nat Commun 14:6858","journal-title":"Nat Commun"},{"key":"250_CR66","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/cam4.272","volume":"3","author":"N Yanagisawa","year":"2014","unstructured":"Yanagisawa N, Hana K, Nakada N, Ichinoe M, Koizumi W, Endou H, Okayasu I, Murakumo Y (2014) High expression of L-type amino acid transporter 1 as a prognostic marker in bile duct adenocarcinomas. Cancer Med 3:1246\u20131255","journal-title":"Cancer Med"},{"key":"250_CR67","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317694545","volume":"39","author":"S Yothaisong","year":"2017","unstructured":"Yothaisong S, Dokduang H, Anzai N, Hayashi K, Namwat N, Yongvanit P, Sangkhamanon S, Jutabha P, Endou H, Loilome W (2017) Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment. Tumour Biol 39:1010428317694545","journal-title":"Tumour Biol"},{"key":"250_CR68","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","volume":"377","author":"R Zeiser","year":"2017","unstructured":"Zeiser R, Blazar BR (2017) Acute graft-versus-host disease - biologic process, prevention, and therapy. N Engl J Med 377:2167\u20132179","journal-title":"N Engl J Med"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00250-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-025-00250-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00250-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T10:21:55Z","timestamp":1786962115000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-025-00250-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":68,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7,11]]}},"alternative-id":["250"],"URL":"https:\/\/doi.org\/10.1038\/s44321-025-00250-2","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"5 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"7"}}